29.1 C
Delhi
Tuesday, October 14, 2025

Dr Reddy Labs launches Lenalidomide Capsules in US

Date:

Share post:

Donate-GC-Razorpay

Mumbai: Dr. Reddy’s Labs on Thursday announced the launch of Lenalidomide Capsules in the US market, , a therapeutic equivalent generic version of REVLIMID (lenalidomide) Capsules approved by U. S. Food and Drug Administration (USFDA).

With this volume-limited launch, Dr. Reddy’s is eligible for first-to-market, 180 days of generic drug exclusivity for Lenalidomide Capsules in 2.5 mg and 20 mg strengths.

‘We are pleased with the first-to-market launch of two of our six strengths of Lenalidomide Capsules with 180-day market exclusivity,” says Marc Kikuchi, CEO, North America Generics, Dr. Reddy’s Laboratories.

“Bringing a more affordable generic version to market creates greater patient access for this important drug.’

Dr. Reddy’s Lenalidomide Capsules are available in strengths of 2.5 mg, 5 mg, and 10 mg, each in a bottle-count size of 28, as well as 15 mg, 20 mg, and 25 mg strengths, each in a bottle-count size of 21.

Related articles

From Kabul to Karachi: the blowback that will dismantle Pakistan

I. From Proxy to PyreIn my earlier analysis, “Noor Wali Mehsud and Pakistan: From Ally to Adversary -...

The U.S. Corn Conspiracy Against India

There is no missile pointed at India’s borders in this war. The weapon is yellow, starchy, and traded...

Donald Trump and the Nobel Peace Prize That Never Was

There are injustices in life that shake the very foundations of faith in humanity - a puppy not...

The Fallacy of Time: There Is Only Now

Time - humanity’s most loyal illusion. We wake up to its tick, work under its watch, and die...